Literature DB >> 15006158

Drug delivery to the posterior segment of the eye II: development and validation of a simple pharmacokinetic model for subconjunctival injection.

Thomas Wai-Yip Lee1, Joseph R Robinson.   

Abstract

The aim of this study was to develop and validate a simple pharmacokinetic model for subconjunctival injection so as to study drug delivery to the posterior segment of the eye using the subconjunctival route. Curve-fitting was performed by ModelMaker 4.0 by applying Tsuji et al.'s in vivo data. It was found that drug elimination from the vitreous chamber was slowed by the existence of a peripheral compartment. The validity of this model was ensured because it gives reasonable predictability at two additional doses. This model is invaluable in studying drug delivery to the back of the eye by subconjunctival injection.

Mesh:

Year:  2004        PMID: 15006158     DOI: 10.1089/108076804772745455

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  11 in total

1.  Ocular pharmacokinetic study of a corticosteroid by 19F MR.

Authors:  Xin Liu; S Kevin Li; Eun-Kee Jeong
Journal:  Exp Eye Res       Date:  2010-06-09       Impact factor: 3.467

2.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

Review 3.  Novel drug delivery systems for glaucoma.

Authors:  E Lavik; M H Kuehn; Y H Kwon
Journal:  Eye (Lond)       Date:  2011-04-08       Impact factor: 3.775

4.  Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.

Authors:  Pradip Malik; Rajendra S Kadam; Narayan P S Cheruvu; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-02-08       Impact factor: 4.939

5.  Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  Int J Pharm       Date:  2006-11-03       Impact factor: 5.875

6.  Examination of barriers and barrier alteration in transscleral iontophoresis.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

7.  Passive and oxymetazoline-enhanced delivery with a lens device: pharmacokinetics and efficacy studies with rabbits.

Authors:  David J Miller; S Kevin Li; Anthony L Tuitupou; Rajan P Kochambilli; Kongnara Papangkorn; Donald C Mix; William I Higuchi; John W Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

8.  Ocular delivery of pRNA nanoparticles: distribution and clearance after subconjunctival injection.

Authors:  Liang Feng; S Kevin Li; Hongshan Liu; Chia-Yang Liu; Kathleen LaSance; Farzin Haque; Dan Shu; Peixuan Guo
Journal:  Pharm Res       Date:  2013-12-03       Impact factor: 4.200

Review 9.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

10.  Modeling of corneal and retinal pharmacokinetics after periocular drug administration.

Authors:  Aniruddha C Amrite; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.